Q1 FY27 — 22 Jul 2026
Medplus Health Services Limited Q1 FY27
MedPlus Health Services reported a robust 21.8% Y-o-Y growth in pharmacy operations revenue for Q1 FY27, with consolidated revenue reaching INR18,796 million. However, operating EBITDA margin compressed to 3.5%, partly due to a contraction in private label share and increased employee costs. The company has paused its diversification capex plans and is addressing challenges in its franchisee model, while maintaining its target of 800 net new store additions for FY27.
Read the full call






